Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults
Clinical trial NCT06684743 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06684743
- Sponsor
- Tor Biering-Sørensen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-18
- Primary completion
- 2028-05-01
- Enrollment
- 690000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.